BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 750,000 Value ($000) $738 Avg Close — Range —
Q4 2024
Shares 2,651,000 Value ($000) $2,261 Avg Close — Range —